Literature DB >> 29520675

Gut Microbiota Alteration After Long-Term Consumption of Probiotics in the Elderly.

Renyuan Gao1,2, Xiaohui Zhang1,2,3, Linsheng Huang1,2, Rongrong Shen1, Huanlong Qin4,5,6.   

Abstract

Gut microbiota has been proven to be of crucial importance in maintaining human health. However, the microbiota profile changes with aging, while the loss of microbiota diversity and the alterations in the optimal composition and quantity of beneficial microbes are believed to increase the risk of many diseases. Although the short-term modulatory impact of probiotics on gut microbiota has been revealed in various studies, no studies focused on longer time consumption of probiotics have been demonstrated. In this study, we found that microbial diversity in the probiotic group was similar to that in the control. We identified a panel of microbiota changes, such as Blautia (10.24 vs. 3.76%, P = 0.006), Streptococcus (7.38 vs. 1.16%, P = 0.004), and Enterococcus (0.13 vs. 0.00%, P = 0.030) were more abundant in the probiotic group. Faecalibacterium, a genus containing anti-inflammatory property, also had a higher abundance in the probiotic group in the gut. The microbiota architecture in the different probiotic dose groups was also revealed. No statistical difference was observed in regard to the short-chain fatty acid concentration between the groups. High-dose intake of probiotics resulted in lower microbial richness. The profile of inflammatory factors indicated that only the level of IL-1β was higher in the probiotic population. Taken together, our study demonstrated that the long-time intake of probiotics caused significant changes in the gut microbiota structure, including an increase in the composition of beneficial microorganisms, which might contribute to the maintenance of host health and homeostasis of microenvironment. More prospective cohorts were needed to illustrate the influences of probiotics on the gut microbiota.

Entities:  

Keywords:  Gut microbiota; Probiotics; Short-chain fatty acid; Time duration

Mesh:

Substances:

Year:  2019        PMID: 29520675     DOI: 10.1007/s12602-018-9403-1

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  10 in total

1.  Effects of Inulin-Based Prebiotics Alone or in Combination with Probiotics on Human Gut Microbiota and Markers of Immune System: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects.

Authors:  Alessandra De Giani; Anna Sandionigi; Jessica Zampolli; Angela Michelotti; Francesco Tursi; Massimo Labra; Patrizia Di Gennaro
Journal:  Microorganisms       Date:  2022-06-20

Review 2.  The gut microbiome as a modulator of healthy ageing.

Authors:  Tarini Shankar Ghosh; Fergus Shanahan; Paul W O'Toole
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-04-25       Impact factor: 73.082

3.  In vitro Study of Lactobacillus paracasei CNCM I-1518 in Healthy and Clostridioides difficile Colonized Elderly Gut Microbiota.

Authors:  Sophie Fehlbaum; Christophe Chassard; Clarissa Schwab; Maarja Voolaid; Candice Fourmestraux; Muriel Derrien; Christophe Lacroix
Journal:  Front Nutr       Date:  2019-12-10

4.  Functional microbiome deficits associated with ageing: Chronological age threshold.

Authors:  Susana Ruiz-Ruiz; Sergio Sanchez-Carrillo; Sergio Ciordia; María C Mena; Celia Méndez-García; David Rojo; Rafael Bargiela; Elisa Zubeldia-Varela; Mónica Martínez-Martínez; Coral Barbas; Manuel Ferrer; Andrés Moya
Journal:  Aging Cell       Date:  2019-11-15       Impact factor: 9.304

5.  Stable Colonization of Orally Administered Lactobacillus casei SY13 Alters the Gut Microbiota.

Authors:  Yuanchun Yue; Xiaoxi Xu; Baoyu Yang; Jing Lu; Shuwen Zhang; Liu Liu; Khaled Nassar; Cai Zhang; Min Zhang; Xiaoyang Pang; Jiaping Lv
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

Review 6.  Review article: the future of microbiome-based therapeutics.

Authors:  Emily L Gulliver; Remy B Young; Michelle Chonwerawong; Gemma L D'Adamo; Tamblyn Thomason; James T Widdop; Emily L Rutten; Vanessa Rossetto Marcelino; Robert V Bryant; Samuel P Costello; Claire L O'Brien; Georgina L Hold; Edward M Giles; Samuel C Forster
Journal:  Aliment Pharmacol Ther       Date:  2022-05-24       Impact factor: 9.524

7.  Clostridium butyricum Potentially Improves Immunity and Nutrition through Alteration of the Microbiota and Metabolism of Elderly People with Malnutrition in Long-Term Care.

Authors:  Lin Liu; Xiang Chen; Lu Liu; Huanlong Qin
Journal:  Nutrients       Date:  2022-08-28       Impact factor: 6.706

8.  Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis.

Authors:  Soo-Kyung Park; Sang-Bum Kang; SangSoo Kim; Tae Oh Kim; Jae Myung Cha; Jong Pil Im; Chang Hwan Choi; Eun Soo Kim; Geom Seog Seo; Chang Soo Eun; Dong Soo Han; Dong Il Park
Journal:  Korean J Intern Med       Date:  2022-03-31       Impact factor: 3.165

9.  Intake of MPRO3 over 4 Weeks Reduces Glucose Levels and Improves Gastrointestinal Health and Metabolism.

Authors:  Songhee Lee; Heesang You; Yeongju Lee; Haingwoon Baik; Jeankyung Paik; Hayera Lee; Soodong Park; Jaejung Shim; Junglyoul Lee; Sunghee Hyun
Journal:  Microorganisms       Date:  2021-12-31

Review 10.  Bifidobacterium Longum: Protection against Inflammatory Bowel Disease.

Authors:  Shunyu Yao; Zixi Zhao; Weijun Wang; Xiaolu Liu
Journal:  J Immunol Res       Date:  2021-07-23       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.